| Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss M Zahoor, M Westhrin, KR Aass, SH Moen, K Misund, ... Blood advances 1 (27), 2656-2666, 2017 | 61 | 2017 |
| Molecular interactions and functions of IL-32 KR Aass, MH Kastnes, T Standal Journal of Leucocyte Biology 109 (1), 143-159, 2021 | 48 | 2021 |
| Paired miRNA-and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma KR Aass, TMV Nedal, SS Tryggestad, E Haukås, TS Slørdahl, A Waage, ... Scientific Reports 12 (1), 12147, 2022 | 16 | 2022 |
| Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells KR Aass, R Mjelle, MH Kastnes, SS Tryggestad, LM van den Brink, ... Iscience 25 (1), 2022 | 9 | 2022 |
| sMETASeq: combined profiling of microbiota and host small RNAs R Mjelle, KR Aass, W Sjursen, E Hofsli, P Sætrom Iscience 23 (5), 2020 | 9 | 2020 |
| IL-32 is induced by activation of toll-like receptors in multiple myeloma cells KR Aass, SS Tryggestad, R Mjelle, MH Kastnes, TMV Nedal, K Misund, ... Frontiers in Immunology 14, 1107844, 2023 | 5 | 2023 |
| Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival K Roseth Aass, TMV Nedal, S Anshushaug Bouma, SS Tryggestad, ... British Journal of Cancer 128 (4), 656-664, 2023 | 5 | 2023 |
| Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk* MYC model of multiple myeloma TMV Nedal, SH Moen, IA Roseth, SS Tryggestad, KR Aass, GG Hov, ... Scientific Reports 14 (1), 3643, 2024 | 2 | 2024 |
| IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells KR Aass, R Mjelle, MH Kastnes, SS Tryggestad, LM van den Brink, ... bioRxiv, 2021.02. 22.431638, 2021 | 2 | 2021 |
| The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes M Kastnes, KR Aass, SA Bouma, C Årseth, M Zahoor, M Yurchenko, ... Frontiers in Oncology 13, 1197542, 2023 | 1 | 2023 |
| Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation … SS Tryggestad, IA Roseth, KR Aass, NEH Ørning, R Mjelle, H Hella, ... Frontiers in Immunology 15, 1393906, 2024 | | 2024 |
| Interpreting single-cell messages in normal and aberrant hematopoiesis with the Cell Marker Accordion E Busarello, G Biancon, F Lauria, Z Ibnat, C Ramirez, G Tomè, KR Aass, ... bioRxiv, 2024 | | 2024 |
| P-218 TLR-activation may promote drug resistance and disease progression in multiple myeloma SS Tryggestad, KR Aass, IA Roseth, T Standal Clinical Lymphoma Myeloma and Leukemia 23, S155, 2023 | | 2023 |
| Martin Kastnes1, Kristin Roseth Aass1, Siri Anshushaug Bouma1, Charlotte Årseth1, Muhammad Zahoor2, Mariia Yurchenko1 and Therese Standal1, 3 M Kastnes, KR Aass, SA Bouma, C Årseth, M Zahoor, M Yurchenko, ... | | 2023 |
| The Role of IL-32 in Multiple Myeloma KR Aass NTNU, 2020 | | 2020 |
| IL-32 and multiple myeloma bone disease KR Aass NTNU, 2016 | | 2016 |
